Programa de trabajo estadístico internacional para América Latina y el Caribe, 1997-1998: Subprograma 1: adaptación y producción de estadísticas básicas en el marco de una estrategia regional para la implementación del Sistema de Cuentas Nacionales 1993 (SCN 1993) = Programme of international statistical work for Latin America and the Caribbean, 1997-1998: Subprogramme 1: adaptation and production of basic statistics in the framework of a regional strategy for the implementation of the System of National Accounts 1993 (SCN 1993)

Incluye Bibliografía

Informe del Seminario Regional de Expertos sobre Comparaciones del Sistema de Cuentas Nacionales y del Sistema de Balances de la Economía Nacional en América Latina = Report of the Regional Seminar of Experts on Comparisons of the System of National Accounts and the System of Balances of the National Economy in Latin America

Incluye Bibliografía

Status of implementation of the System of National Accounts (SNA) 1993 in selected Caribbean countries

Includes bibliography

Avance en la aplicación del Sistema de Cuentas Nacionales (SCN, 1993) en los países de América Latina y el Caribe, 1996 = Progress in implementing the System of National Accounts (SNA 1993) in Latin American and Caribbean countries, 1996

Incluye Bibliografía

Terminología utilizada en la traducción del Sistema de Cuentas Nacionales 1993 (SCN 1993) = Terminology used in the translation of the System of National Accounts 1993 (1993 SNA)

Glosario español-inglés, inglés-español

Avance en la aplicación del Sistema de Cuentas Nacionales (SCN, 1993) en los países de América Latina y el Caribe, 1997 = Progress in implementing the System of National Accounts (1993 SNA) in Latin American and Caribbean countries, 1997

Incluye Bibliografía

Progress in implementing the 1993 System of National Accounts (SNA 1993) in Latin America and the Caribbean, 1998-1999

Includes bibliography

The Brazilian National Health Agency and the Mental Health Policy in the Context of the Private Health System: developments and challenges

This work analyses the mental health policy-making activity of the Brazilian National Health Agency (ANS), responsible for controlling health insurance companies. Three points are discussed: a) the framework of an economic and private health assistance regulatory activity, b) the ANS and its regulation activity and c) the rules produced by ANS in the mental health care field. It was concluded that, despite advances like the legal obligation to ensure medical treatment to all the diseases listed in ICD-10, the inclusion of suicidal patient damage and self-inflicted damage care, care provided by a multiprofessional team, the increase in the number of sessions with a psychologist, with an occupational therapist and of psychotherapy sessions, and mental health day hospitals included as part of the services offered, the authors identified specific regulatory gaps in this area. Some issues that ANS has to solve so that it can really play its institutional role of defending the public interest in the private health system are: the regulation of co-participation and franchise mechanisms, the increasing co-participation as a limitation of psychiatric hospitalization, and the limited number of crisis intervention psychotherapy sessions.

Safety of non-therapeutic atomoxetine exposures - a national poison data system study

AIMS This study's objective is to assess the safety of non-therapeutic atomoxetine exposures reported to the US National Poison Database System (NPDS). METHODS This is a retrospective database study of non-therapeutic single agent ingestions of atomoxetine in children and adults reported to the NPDS between 2002 and 2010. RESULTS A total of 20 032 atomoxetine exposures were reported during the study period, and 12 370 of these were single agent exposures. The median age was 9 years (interquartile range 3, 14), and 7380 were male (59.7%). Of the single agent exposures, 8813 (71.2%) were acute exposures, 3315 (26.8%) were acute-on-chronic, and 166 (1.3%) were chronic. In 10 608 (85.8%) cases, exposure was unintentional, in 1079 (8.7%) suicide attempts, and in 629 (5.1%) cases abuse. Of these cases, 3633 (29.4 %) were managed at health-care facilities. Acute-on-chronic exposure was associated with an increased risk of a suicidal reason for exposure compared with acute ingestions (odds ratio 1.44, 95% confidence interval 1.26-1.65). Most common clinical effects were drowsiness or lethargy (709 cases; 5.7%), tachycardia (555; 4.5%), and nausea (388; 3.1%). Major toxicity was observed in 21 cases (seizures in nine (42.9%), tachycardia in eight (38.1%), coma in six (28.6%), and ventricular dysrhythmia in one case (4.8%)). CONCLUSIONS Non-therapeutic atomoxetine exposures were largely safe, but seizures were rarely observed.